| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |